Stocks / NASDAQ / Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc.

Our Opinion

Trevi Therapeutics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

The company announced in the following press release that, “Nalbuphine ER is an oral extended release opioid with a unique opioid receptor dual agonist/antagonist mechanism of action, which has shown efficacy in addressing pruritus in both animal studies and human clinical trials.” Read the full article.

Company Description

Company Website: